itraconazole has been researched along with ravuconazole in 44 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 5 (11.36) | 18.2507 |
2000's | 24 (54.55) | 29.6817 |
2010's | 6 (13.64) | 24.3611 |
2020's | 9 (20.45) | 2.80 |
Authors | Studies |
---|---|
Coleman, DC; Gee, S; Joly, S; Messer, SA; Pfaller, MA; Pujol, C; Soll, DR; Sullivan, DJ | 1 |
Diekema, DJ; Doern, GV; Hollis, RJ; Houston, A; Jones, RN; Messer, SA; Pfaller, MA | 1 |
Bonner, DP; Fung-Tomc, JC; Huczko, E; Minassian, B; White, TC | 1 |
Denning, DW; Moore, CB; Walls, CM | 1 |
Hollis, RJ; Houston, A; Jones, RN; Messer, SA; Pfaller, MA; Yamazumi, T | 1 |
Calderon, L; Clemons, KV; Martinez, M; Stevens, DA | 1 |
Ichihara, S; Murasaki, C; Ohwada, J; Shimma, N; Umeda, I; Yamazaki, T | 1 |
Kamei, K | 1 |
Diekema, DJ; Hollis, RJ; Jones, RN; Messer, SA; Pfaller, MA | 1 |
Bonner, D; Fung-Tomc, J; Huczko, E; Minassian, B; Washo, T | 1 |
Capilla, J; Guarro, J; Javier Pastor, F; Ortoneda, M; Pujol, I | 1 |
Batra, R; Gupta, AK; Kohli, Y | 1 |
Steinbach, WJ | 1 |
Cano, J; Gené, J; Gilgado, F; Guarro, J; Serena, C | 1 |
Denning, DW; Gardiner, RE; Howard, SJ; Moore, CB; Park, S; Perlin, DS; Webster, I | 1 |
Alastruey-Izquierdo, A; Alcazar-Fuoli, L; Cuenca-Estrella, M; Mellado, E; Monzon, A; Rodriguez-Tudela, JL | 1 |
Ayala, J; Elizondo, M; González, GM | 1 |
Dannaoui, E; Lortholary, O; Schwarz, P | 1 |
Vera-Cabrera, L; Welsh, E; Welsh, O | 1 |
Guarro, J; Mayayo, E; Pastor, FJ; Pujol, I; Ruíz-Cendoya, M; Sutton, DA | 1 |
Ahmed, SA; de Hoog, GS; Duncanson, F; Fahal, AH; Kloezen, W; van de Sande, WW; Zijlstra, EE | 1 |
Ikeda, F; Iyoda, T; Mikawa, T; Suzuki, M; Yamaguchi, H | 1 |
Aramaki, C; Kamata, H; Kano, R; Mori, Y; Murayama, N; Yamagishi, K; Yokoi, S | 1 |
Ito, T; Kamata, H; Kano, R; Miura, A; Suzuki, K | 1 |
Harada, K; Hase, M; Hiruma, J; Hiruma, M; Kamata, H; Kano, R; Noguchi, H; Yokota, M | 1 |
Abastabar, M; Badali, H; Bonifaz, A; Fahal, A; Lim, W; Nyuykonge, B; van Amelsvoort, L; van de Sande, W; Verbon, A | 1 |
Bakhiet, S; Fahal, AH; Mhmoud, NA; Nyaoke, BA; Nyuykonge, B; Siddig, EE; van de Sande, WWJ; Verbon, A; Zijlstra, EE | 1 |
Hirasawa, Y; Hiruma, M; Ikeda, S; Kano, R; Komiyama, E; Ogawa, T; Ogawa, Y; Tsuchihashi, H; Watanabe, M | 1 |
Harada, K; Hiruma, J; Hiruma, M; Kano, R; Noguchi, H; Shimizu, T | 1 |
Harada, K; Hiruma, J; Hiruma, M; Kano, R; Makimura, K; Noguchi, H; Nojo, H | 1 |
Algueró, M; Bartroli, J; Boncompte, E; Conte, L; Forn, J; García-Rafanell, J; Merlos, M; Ramis, J; Turmo, E; Vericat, ML | 2 |
Alcázar-Fuoli, L; Cuenca-Estrella, M; Garcia-Effron, G; Melchers, WJ; Mellado, E; Rodríguez-Tudela, JL; Verweij, PE | 1 |
Cano, J; Gené, J; Guarro, J; Marimon, R; Serena, C | 1 |
Alastruey-Izquierdo, A; Alcazar-Fuoli, L; Cuenca-Estrella, M; Mellado, E; Rodriguez-Tudela, JL | 2 |
Alastruey-Izquierdo, A; Almirante, B; Cuenca-Estrella, M; Gomez-Lopez, A; Pahissa, A; Rodriguez, D; Rodriguez-Tudela, JL | 1 |
Azor, M; Cano, J; Fothergill, AW; Gené, J; Guarro, J; Rinaldi, MG; Sutton, DA | 1 |
Alastruey-Izquierdo, A; Castelli, MV; Cuenca-Estrella, M; Cuesta, I; Mellado, E; Monzon, A; Rodriguez-Tudela, JL | 1 |
Alastruey-Izquierdo, A; Cuenca-Estrella, M; Lass-Flörl, C; Perkhofer, S; Rodriguez-Tudela, JL | 1 |
Alastruey-Izquierdo, A; Castelli, MV; Cuenca-Estrella, M; Cuesta, I; Monzon, A; Rodriguez-Tudela, JL | 1 |
Alastruey-Izquierdo, A; Cuenca-Estrella, M; Cuesta, I; Rodriguez-Tudela, JL; Walther, G | 1 |
Cai, T; Cao, X; Cao, Y; Chu, W; Hu, W; Sun, Z; Wang, R; Yang, Y | 1 |
Emami, S; Ghobadi, E; Saednia, S | 1 |
4 review(s) available for itraconazole and ravuconazole
Article | Year |
---|---|
[Present status and future prospects of azole antifungal agents in Japan].
Topics: Antifungal Agents; Azoles; Cyclodextrins; Drug Design; Fluconazole; Forecasting; Itraconazole; Japan; Miconazole; Pyrimidines; Thiazoles; Triazoles; Voriconazole | 2002 |
Antifungal agents in children.
Topics: Age Factors; Amphotericin B; Anidulafungin; Antifungal Agents; Caspofungin; Chemistry, Pharmaceutical; Child; Clinical Trials as Topic; Drug Approval; Drug Resistance, Fungal; Echinocandins; Fluconazole; Flucytosine; Humans; Itraconazole; Lipopeptides; Lipoproteins; Micafungin; Mycoses; Patient Selection; Pediatrics; Peptides, Cyclic; Pyrimidines; Safety; Thiazoles; Triazoles; United States; Voriconazole | 2005 |
Onychomycosis.
Topics: Administration, Cutaneous; Administration, Oral; Antifungal Agents; Ciclopirox; Drug Administration Schedule; Drug Therapy, Combination; Fluconazole; Foot Dermatoses; Humans; Itraconazole; Mitosporic Fungi; Morpholines; Naphthalenes; Onychomycosis; Pyridones; Pyrimidines; Terbinafine; Thiazoles; Triazoles; Voriconazole | 2010 |
Synthetic approaches and structural diversity of triazolylbutanols derived from voriconazole in the antifungal drug development.
Topics: Antifungal Agents; Drug Development; Fungi; Voriconazole | 2022 |
40 other study(ies) available for itraconazole and ravuconazole
Article | Year |
---|---|
In vitro susceptibilities of Candida dubliniensis isolates tested against the new triazole and echinocandin antifungal agents.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Candida; Candidiasis; Caspofungin; Echinocandins; Fluconazole; Flucytosine; Humans; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Peptides; Peptides, Cyclic; Pyrimidines; Thiazoles; Triazoles; Voriconazole | 1999 |
In vitro activities of BMS-207147 against over 600 contemporary clinical bloodstream isolates of Candida species from the SENTRY Antimicrobial Surveillance Program in North America and Latin America.
Topics: Antifungal Agents; Candida; Dose-Response Relationship, Drug; Fluconazole; Humans; Itraconazole; Latin America; Microbial Sensitivity Tests; North America; Population Surveillance; Thiazoles; Triazoles | 1999 |
In vitro antifungal activity of BMS-207147 and itraconazole against yeast strains that are non-susceptible to fluconazole.
Topics: Antifungal Agents; Candida; Drug Resistance, Microbial; Fluconazole; Itraconazole; Microbial Sensitivity Tests; Thiazoles; Triazoles | 1999 |
In vitro activity of the new triazole BMS-207147 against Aspergillus species in comparison with itraconazole and amphotericin B.
Topics: Amphotericin B; Antifungal Agents; Aspergillus; Drug Resistance, Microbial; Humans; Itraconazole; Microbial Sensitivity Tests; Thiazoles; Triazoles | 2000 |
In vitro activities of ravuconazole (BMS-207147) against 541 clinical isolates of Cryptococcus neoformans.
Topics: Antifungal Agents; Cryptococcosis; Cryptococcus neoformans; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests; Thiazoles; Triazoles | 2000 |
Efficacy of ravuconazole in treatment of systemic murine histoplasmosis.
Topics: Animals; Antifungal Agents; Colony Count, Microbial; Female; Fluconazole; Histoplasmosis; Itraconazole; Liver; Mice; Spleen; Survival; Survival Analysis; Thiazoles; Triazoles | 2002 |
Synthesis of novel water soluble benzylazolium prodrugs of lipophilic azole antifungals.
Topics: Animals; Antifungal Agents; Aspergillus fumigatus; Azoles; Candida albicans; Candidiasis; Chemical Phenomena; Chemistry, Physical; Half-Life; Humans; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Prodrugs; Rats; Solubility; Thiazoles; Triazoles | 2002 |
Activities of caspofungin, itraconazole, posaconazole, ravuconazole, voriconazole, and amphotericin B against 448 recent clinical isolates of filamentous fungi.
Topics: Amphotericin B; Anti-Bacterial Agents; Aspergillus; Caspofungin; Echinocandins; Fungi; Humans; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Mycoses; Penicillium; Peptides; Peptides, Cyclic; Pyrimidines; Thiazoles; Triazoles; Voriconazole | 2003 |
In vitro activity of ravuconazole against Zygomycetes, Scedosporium and Fusarium isolates.
Topics: Amphotericin B; Antifungal Agents; Fungi; Fusarium; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Scedosporium; Thiazoles; Triazoles; Voriconazole | 2003 |
In vitro interactions of licensed and novel antifungal drugs against Fusarium spp.
Topics: Amphotericin B; Antifungal Agents; Drug Interactions; Drug Resistance, Fungal; Fusarium; Humans; Itraconazole; Microbial Sensitivity Tests; Naphthalenes; Pyrimidines; Quinazolines; Sensitivity and Specificity; Terbinafine; Thiazoles; Triazoles; Voriconazole | 2004 |
In vitro activities of posaconazole, ravuconazole, terbinafine, itraconazole and fluconazole against dermatophyte, yeast and non-dermatophyte species.
Topics: Antifungal Agents; Arthrodermataceae; Fluconazole; Fungi; Humans; Itraconazole; Microbial Sensitivity Tests; Mycoses; Naphthalenes; Terbinafine; Thiazoles; Triazoles; Yeasts | 2005 |
Antifungal susceptibilities of the species of the Pseudallescheria boydii complex.
Topics: Amphotericin B; Antifungal Agents; Candida; Drug Resistance, Fungal; Echinocandins; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Lipopeptides; Lipoproteins; Micafungin; Microbial Sensitivity Tests; Naphthalenes; Peptides, Cyclic; Pseudallescheria; Pyrimidines; Quality Control; Quinazolines; Scedosporium; Terbinafine; Thiazoles; Triazoles; Voriconazole | 2006 |
Multi-azole resistance in Aspergillus fumigatus.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Caspofungin; Cytochrome P-450 Enzyme System; Drug Resistance, Multiple, Fungal; Echinocandins; Fungal Proteins; Humans; Itraconazole; Lipopeptides; Lung Diseases, Fungal; Male; Microbial Sensitivity Tests; Middle Aged; Mutation, Missense; Peptides, Cyclic; Pyrimidines; Thiazoles; Triazoles; Voriconazole | 2006 |
Epidemiological cutoffs and cross-resistance to azole drugs in Aspergillus fumigatus.
Topics: Amino Acid Substitution; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Azoles; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Fungal Proteins; Genes, Fungal; Humans; Itraconazole; Microbial Sensitivity Tests; Molecular Epidemiology; Molecular Sequence Data; Pyrimidines; Thiazoles; Triazoles; Voriconazole | 2008 |
Trends in species distribution and susceptibility of bloodstream isolates of Candida collected in Monterrey, Mexico, to seven antifungal agents: results of a 3-year (2004 to 2007) surveillance study.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Candida; Candida albicans; Candida glabrata; Candida tropicalis; Candidiasis; Caspofungin; Child; Child, Preschool; Echinocandins; Female; Fluconazole; Humans; Infant; Infant, Newborn; Itraconazole; Lipopeptides; Male; Mexico; Microbial Sensitivity Tests; Middle Aged; Pyrimidines; Thiazoles; Triazoles; Voriconazole; Young Adult | 2008 |
In vitro interactions between antifungals and immunosuppressive drugs against zygomycetes.
Topics: Amphotericin B; Antifungal Agents; Azoles; Cyclosporine; Drug Interactions; Immunosuppressive Agents; Itraconazole; Microbial Sensitivity Tests; Mucorales; Rhizopus; Sirolimus; Tacrolimus; Thiazoles; Triazoles | 2009 |
In vitro and in vivo antifungal susceptibilities of the Mucoralean fungus Cunninghamella.
Topics: Amphotericin B; Animals; Antifungal Agents; Caspofungin; Cunninghamella; Diabetes Mellitus, Experimental; Echinocandins; Itraconazole; Lipopeptides; Male; Mice; Microbial Sensitivity Tests; Mucormycosis; Pyrimidines; Thiazoles; Triazoles; Voriconazole | 2010 |
Madurella mycetomatis is highly susceptible to ravuconazole.
Topics: Antifungal Agents; Itraconazole; Ketoconazole; Madurella; Microbial Sensitivity Tests; Thiazoles; Triazoles | 2014 |
[In vitro antifungal activity of ravuconazole against isolates of dermatophytes and Candida species from patients with dermatomycoses].
Topics: Antifungal Agents; Arthrodermataceae; Candida; Dermatomycoses; Dose-Response Relationship, Drug; Drug Resistance, Fungal; Humans; Itraconazole; Naphthalenes; Terbinafine; Thiazoles; Triazoles | 2014 |
High multi-azole-resistant Malassezia pachydermatis clinical isolates from canine Malassezia dermatitis.
Topics: Animals; Antifungal Agents; Azoles; Dermatomycoses; Dog Diseases; Dogs; Drug Resistance, Multiple, Fungal; Itraconazole; Japan; Malassezia; Microbial Sensitivity Tests; Thiazoles; Triazoles | 2020 |
In vitro algaecid effect of itraconazole and ravuconazole on Prototheca species.
Topics: Humans; Infections; Itraconazole; Microbial Sensitivity Tests; Prototheca; Thiazoles; Triazoles | 2020 |
In Vitro Ravuconazole Susceptibility of Anthropophilic Dermatophyte Strains Isolated from Japanese Patients.
Topics: Antifungal Agents; Arthrodermataceae; Dermatomycoses; Drug Resistance, Fungal; Humans; Itraconazole; Microbial Sensitivity Tests; Terbinafine; Thiazoles; Triazoles | 2020 |
Eumycetoma causative agents are inhibited in vitro by luliconazole, lanoconazole and ravuconazole.
Topics: Antifungal Agents; Humans; Imidazoles; Itraconazole; Madurella; Mycetoma; Thiazoles; Triazoles | 2022 |
Epidemiological cut-off values for itraconazole and ravuconazole for Madurella mycetomatis, the most common causative agent of mycetoma.
Topics: Antifungal Agents; Humans; Itraconazole; Madurella; Mycetoma; Triazoles | 2022 |
Antifungal Susceptibility Testing for Microsporum canis from Cats in Japan.
Topics: Animals; Antifungal Agents; Canidae; Cats; Itraconazole; Japan; Terbinafine; Tinea | 2023 |
Epidemiological study of antifungal-resistant dermatophytes isolated from Japanese patients.
Topics: Antifungal Agents; East Asian People; Humans; Itraconazole; Microbial Sensitivity Tests; Terbinafine; Trichophyton | 2023 |
In vitro Azole Susceptibility Testing of Japanese Isolates of Itraconazole-Resistant Dermatophytes.
Topics: Antifungal Agents; Arthrodermataceae; Azoles; Drug Resistance, Fungal; Itraconazole; Microbial Sensitivity Tests; Terbinafine; Trichophyton | 2023 |
New azole antifungals. 2. Synthesis and antifungal activity of heterocyclecarboxamide derivatives of 3-amino-2-aryl-1-azolyl-2-butanol.
Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Candidiasis; Colony Count, Microbial; Fungi; Male; Mice; Molecular Conformation; Pyrimidinones; Rats; Stereoisomerism; Structure-Activity Relationship; Thiazoles; Thiophenes; Triazoles | 1998 |
New azole antifungals. 3. Synthesis and antifungal activity of 3-substituted-4(3H)-quinazolinones.
Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Candidiasis; Colony Count, Microbial; Fungi; Male; Mice; Molecular Conformation; Quinazolines; Rabbits; Rats; Rats, Sprague-Dawley; Stereoisomerism; Structure-Activity Relationship; Triazoles | 1998 |
A new Aspergillus fumigatus resistance mechanism conferring in vitro cross-resistance to azole antifungals involves a combination of cyp51A alterations.
Topics: Amino Acid Substitution; Antifungal Agents; Aspergillus fumigatus; Azoles; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Fungal Proteins; Genotype; Humans; Microbial Sensitivity Tests; Tandem Repeat Sequences | 2007 |
In vitro antifungal susceptibilities of five species of sporothrix.
Topics: Animals; Antifungal Agents; Drug Resistance, Fungal; Humans; Microbial Sensitivity Tests; Species Specificity; Sporothrix; Sporotrichosis | 2008 |
Aspergillus section Fumigati: antifungal susceptibility patterns and sequence-based identification.
Topics: Antifungal Agents; Aspergillus fumigatus; Fungal Proteins; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Nuclear Proteins; Phylogeny; Polymerase Chain Reaction; Sequence Analysis, DNA; Tubulin | 2008 |
Prevalence and susceptibility profile of Candida metapsilosis and Candida orthopsilosis: results from population-based surveillance of candidemia in Spain.
Topics: Antifungal Agents; Candida; Candidiasis; Fungemia; Humans; Microbial Sensitivity Tests; Population Surveillance; Prevalence; Spain; Species Specificity | 2008 |
In vitro antifungal susceptibility and molecular characterization of clinical isolates of Fusarium verticillioides (F. moniliforme) and Fusarium thapsinum.
Topics: Animals; Antifungal Agents; Drug Resistance, Fungal; Fusarium; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Mycoses; Naphthalenes; Sequence Analysis, DNA; Terbinafine; Triazoles; Tubulin | 2008 |
Susceptibility testing and molecular classification of Paecilomyces spp.
Topics: Amphotericin B; Antifungal Agents; DNA, Fungal; DNA, Ribosomal; Echinocandins; Itraconazole; Microbial Sensitivity Tests; Paecilomyces; Phylogeny | 2008 |
In vitro activities of various antifungal drugs against Aspergillus terreus: Global assessment using the methodology of the European committee on antimicrobial susceptibility testing.
Topics: Antifungal Agents; Aspergillosis; Aspergillus; DNA, Fungal; Humans; Microbial Sensitivity Tests; Soil Microbiology | 2009 |
Activity of posaconazole and other antifungal agents against Mucorales strains identified by sequencing of internal transcribed spacers.
Topics: Amphotericin B; Antifungal Agents; DNA, Ribosomal Spacer; Microbial Sensitivity Tests; Mucorales; Triazoles | 2009 |
Species identification and antifungal susceptibility patterns of species belonging to Aspergillus section Nigri.
Topics: Antifungal Agents; Aspergillus; Itraconazole; Microbial Sensitivity Tests; Molecular Sequence Data; Phylogeny | 2009 |
Antifungal susceptibility profile of human-pathogenic species of Lichtheimia.
Topics: Amphotericin B; Antifungal Agents; Humans; Microbial Sensitivity Tests; Mucorales; Pyrimidines; Triazoles; Voriconazole | 2010 |
Design, synthesis, and structure-activity relationship studies of novel fused heterocycles-linked triazoles with good activity and water solubility.
Topics: Animals; Antifungal Agents; Area Under Curve; Candida; Drug Design; Drug Evaluation, Preclinical; Half-Life; Heterocyclic Compounds; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Molecular Docking Simulation; Rats; Solubility; Structure-Activity Relationship; Triazoles; Water | 2014 |